Skip to Main Content

Paper Details

Treatment-free remission after ceasing venetoclax-based therapy in patients with acute myeloid leukemia.
Blood Adv
26
2022
Author NameAffiliation
Daniel A PollyeaUniversity of Colorado School of Medicine
Courtney D DiNardoUniversity of Texas MD Anderson Cancer Center
  • 1 - 2

Datasets

Release 1.2